Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Landmark trials affecting the surgical management of invasive breast cancer.

Black DM, Mittendorf EA.

Surg Clin North Am. 2013 Apr;93(2):501-18. doi: 10.1016/j.suc.2012.12.007. Epub 2013 Jan 29. Review.

2.

Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.

Shapiro-Wright HM, Julian TB.

J Natl Cancer Inst Monogr. 2010;2010(41):145-9. doi: 10.1093/jncimonographs/lgq026. Review.

3.

[Management of the axilla in breast cancer: evidences and unresolved issues].

Fodor J, Polgár C, Péley G, Németh G.

Orv Hetil. 2001 Sep 9;142(36):1941-50. Review. Hungarian.

PMID:
11680099
4.

Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ.

J Natl Cancer Inst. 2006 May 3;98(9):599-609. Erratum in: J Natl Cancer Inst. 2006 Jun 21;98(12):876.

PMID:
16670385
5.

Axillary node interventions in breast cancer: a systematic review.

Rao R, Euhus D, Mayo HG, Balch C.

JAMA. 2013 Oct 2;310(13):1385-94. doi: 10.1001/jama.2013.277804. Review.

PMID:
24084924
6.

Surgical management of early stage invasive breast cancer: a practice guideline.

McCready D, Holloway C, Shelley W, Down N, Robinson P, Sinclair S, Mirsky D; Breast Cancer Disease Site Group of Cancer Care; Ontario's Program in Evidence-Based Care.

Can J Surg. 2005 Jun;48(3):185-94.

7.

Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?

Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.

Chir Ital. 2007 Sep-Oct;59(5):693-9.

PMID:
18019642
8.

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07).

van Roozendaal LM, de Wilt JH, van Dalen T, van der Hage JA, Strobbe LJ, Boersma LJ, Linn SC, Lobbes MB, Poortmans PM, Tjan-Heijnen VC, Van de Vijver KK, de Vries J, Westenberg AH, Kessels AG, Smidt ML.

BMC Cancer. 2015 Sep 3;15:610. doi: 10.1186/s12885-015-1613-2.

9.

Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?

Fu Y, Chung D, Cao MA, Apple S, Chang H.

Ann Surg Oncol. 2014 Dec;21(13):4109-23. doi: 10.1245/s10434-014-3814-3. Epub 2014 Aug 1.

PMID:
25081336
10.

Will we need lymph node dissection at all in the future?

Bourez RL, Rutgers EJ, Van De Velde CJ.

Clin Breast Cancer. 2002 Dec;3(5):315-22; discussion 323-5. Review.

PMID:
12533260
11.

Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.

Yegiyants S, Romero LM, Haigh PI, DiFronzo LA.

Arch Surg. 2010 Jun;145(6):564-9. doi: 10.1001/archsurg.2010.84.

PMID:
20566977
12.

Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?

Biolchini F, Vicentini M, Di Felice E, Giovanardi F, Antonio L, Giorgi Rossi P, Annessi V.

Tumori. 2015 May-Jun;101(3):298-305. doi: 10.5301/tj.5000281. Epub 2015 Apr 2.

PMID:
25838248
13.

Preceding sentinel node biopsy in early breast cancer: does it affect the number of axillary lymph nodes?

Braems G, Denys H, Cocquyt V, Van den Broecke R.

Acta Chir Belg. 2008 Nov-Dec;108(6):691-5.

PMID:
19241919
14.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
15.

Patients with breast cancer and positive sentinel nodes: axillary dissection or axillary radiotherapy?

Zippel D, Papa M.

Arch Surg. 2003 Oct;138(10):1159. No abstract available.

PMID:
14557139
16.

Axillary lymph node clearance in patients with positive sentinel lymph node biopsy.

Hussain T, Kneeshaw PJ.

Ann R Coll Surg Engl. 2014 Apr;96(3):199-201. doi: 10.1308/003588414X13814021678592.

17.

Axillary lymph node dissection in patients with breast cancer and sentinel lymph node micrometastasis or isolated tumor cells: is it necessary?

Attene F, Paliogiannis P, Scognamillo F, Trignano E, Pala C, Trignano M.

Tumori. 2012 May-Jun;98(3):320-3. doi: 10.1700/1125.12399.

PMID:
22825507
18.

Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.

Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A.

J Surg Oncol. 2006 Feb 1;93(2):109-19.

PMID:
16425290
19.
20.

Repeat surgery following breast conservation and intra-operative sentinel lymph node analysis for breast cancer.

Dabbas N, Cutress RI, Wise M, Yiangou C, Agrawal A.

Surgeon. 2013 Oct;11(5):235-40. doi: 10.1016/j.surge.2012.12.008. Epub 2013 Feb 28.

PMID:
23453370

Supplemental Content

Support Center